🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

9689+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 9689 recruiting trials

RecruitingNCT07438691

Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian Study

👨‍⚕️ Riccardo Coletta, Meyer IRCSS📍 21 sites📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07377578

A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma

🏥 Guangzhou Lupeng Pharmaceutical Company LTD.📍 2 sites📅 Started Feb 2026View details ↗
NARecruitingNCT07222475

Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease

👨‍⚕️ C. Robert Bennett, PhD, Mayo Clinic📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07399704

A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease

🏥 Azafaros A.G.📍 3 sites📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07471789

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

🏥 Gyala Therapeutics📍 2 sites📅 Started Feb 2026View details ↗
RecruitingNCT06447064

Cancer Loyalty Card Study 2 (CLOCS-2)

👨‍⚕️ Dr James Flanagan, Imperial College London📍 1 site📅 Started Feb 2026View details ↗
NARecruitingNCT07447011

Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea

👨‍⚕️ Ali MA Ismail, lecturer, Cairo University📍 1 site📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07480954

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

🏥 Beijing Biotech📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07228624

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

👨‍⚕️ Rachel Salit, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07411690

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

👨‍⚕️ Michal Senger, M.D., Department of Neurosurgery, Medical University of Warsaw, Warsaw, Poland📍 1 site📅 Started Feb 2026View details ↗
EARLY_Phase 1RecruitingNCT07441525

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07431281

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

🏥 AstraZeneca📍 230 sites📅 Started Feb 2026View details ↗
Phase 4RecruitingNCT07247058

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

👨‍⚕️ Amir Hamrahian, MD, Johns Hopkins University📍 1 site📅 Started Feb 2026View details ↗
Enrolling by InvitationNCT07254702

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

🏥 Valneva Austria GmbH📍 4 sites📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07224360

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

👨‍⚕️ Study Director, CSL Behring📍 3 sites📅 Started Feb 2026View details ↗
Phase 1RecruitingNCT07480941

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

🏥 Beijing Biotech📍 1 site📅 Started Feb 2026View details ↗
Phase 1, PHASE2RecruitingNCT07480213

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

🏥 Beijing Biotech📍 1 site📅 Started Feb 2026View details ↗
Enrolling by InvitationNCT07347002

Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

🏥 Valneva Austria GmbH📍 4 sites📅 Started Feb 2026View details ↗
Enrolling by InvitationNCT07413224

Qualitative Effects of AEF0217 in Down Syndrome People

👨‍⚕️ Pier Vincenzo Piazza, MD, PhD, Aelis Farma📍 1 site📅 Started Feb 2026View details ↗
Phase 3RecruitingNCT07322003

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

🏥 Prilenia📍 5 sites📅 Started Feb 2026View details ↗
← PreviousPage 16 of 485Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →